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Abstract 15-Lipoxygenases and phospholipid hydroperoxide
glutathione peroxidases (PH-GPx) are counterparts in the
metabolism of hydroperoxy lipids and a balanced regulation of
both enzymes appears to be important for the cellular peroxide
tone regulating the expression of redox sensitive genes. In
contrast to lipoxygenases the molecular biology of PH-GPx is
less well investigated. In this study we cloned the PH-GPx cDNA
from a mouse fibroblast cDNA library and the PH-GPx gene
from a mouse genomic library. The gene spans approximately
4 kb which includes 1 kb of 5P-flanking region and consists of
seven exons and six introns. The immediate promoter region does
not contain a TATA box but there are binding sites for several
transcription factors which also occur in the porcine gene. Our
investigations provide useful tools for future targeted gene
disruption studies.
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1. Introduction
The phospholipid hydroperoxide glutathione peroxidase
(PH-GPx) has been characterized as a peculiar isoform of
selenium dependent glutathione peroxidases [1] which is capa-
ble of reducing ester lipid hydroperoxides such as hydroper-
oxy phospholipids or hydroperoxy cholesterol esters [2^4].
Like other glutathione peroxidases [5,6], the PH-GPx has
been implicated in defense mechanisms protecting cells from
oxidative stress and there are several lines of experimental
evidence supporting this hypothesis [7^10]. On the other
hand, the tissue distribution [11] and the regulation of PH-
GPx expression [12,13] may point to a more speci¢c role of
PH-GPx in cell development and/or di¡erentiation, particu-
larly in spermatogenesis [14^16]. In addition, the enzyme
may be of regulatory importance for the activity of enzymes
involved in the arachidonic acid cascade [17^20]. An endoge-
nous lipoxygenase inhibitor was recently puri¢ed from the
human epidermoid carcinoma cell line A431 and was identi-
¢ed as PH-GPx [21].
More detailed investigations on the biological importance
of mammalian PH-GPx have been hampered so far because of
two reasons: (i) there is no speci¢c PH-GPx inhibitor and (ii)
targeted gene disruption is impossible so far, as the mouse
PH-GPx gene has not been cloned. Although cDNAs for var-
ious mammalian PH-GPx isoforms have already been se-
quenced [22^25], the only complete PH-GPx gene sequenced
so far is that from pigs [26]. In addition, a partial sequence for
the human PH-GPx gene was recently reported in which the
promoter region is lacking [27].
To provide the tools for future gene disruption studies we
cloned the gene of the mouse PH-GPx, including 1 kb of the
5P-£anking region. The structures of the mouse, porcine and
human PH-GPx genes were compared with respect to their
overall structure, and conserved regulatory elements in the
promoter region were identi¢ed.
2. Materials and methods
2.1. Chemicals
The chemicals used were from the following sources: trisodium
citrate dihydrate, magnesium sulfate heptahydrate from Sigma (Dei-
senhofen, Germany); tris(hydroxymethyl)aminomethane (Tris), so-
dium hydroxide and sodium chloride from Merck (Darmstadt, Ger-
many); the pGEM-T cloning vector system from Promega
(Mannheim, Germany); sodium dodecylsulfate from Serva (Heidel-
berg, Germany); PWO DNA polymerase, agarose and ampicillin
from Boehringer Mannheim (Mannheim, Germany); restriction endo-
nucleases from New England Biolabs GmbH (Schwalbach, Ger-
many); bacto yeast extract, bacto agar, and bacto tryptone from
Difco (Detroit, MI, USA); Hybond-N blotting membrane from
Amersham Life Science (Braunschweig, Germany). The human PH-
GPx cDNA (pBSGPX4 construct) was purchased from ATCC (Rock-
ville, MD, USA).
2.2. Cloning procedure
A mouse ¢broblast cDNA library (5P-STRECH PLUS, Clontech,
Palo Alto, California, USA) was screened by hybridization using a
SmaI-PpuMI fragment (480 bp) of the human PH-GPx cDNA as
probe. Among some 300 000 recombinants we isolated a homogeneous
PH-GPx positive plaque during three rounds of hybridization and
PCR screens. Sequencing of the DNA isolated from this plaque in-
dicated that it contained the entire coding region of the mouse PH-
GPx, the complete 3P-untranslated region including the poly A signal
as well as 25 bp of the 5P-untranslated region.
In order to obtain sequence information on the mouse PH-GPx
gene we screened a once ampli¢ed mouse genomic library which
was constructed by inserting BamHI fragments of genomic DNA
into the phage EMBL3 SP6/T7 (Clontech, Palo Alto, CA, USA).
For hydridization screening two probes were prepared from the
mouse PH-GPx cDNA (an EcoRI-NheI fragment of 467 bp and a
NheI-EcoRI fragment of 258 bp). During the primary screen eight
PH-GPx positive plaques were identi¢ed by hybridization among
some 210 000 recombinants. These clones were picked and tested for
PH-GPx by PCR. For construction of the primers we assumed that
the exon/intron organization of the mouse PH-GPx gene was similar
to that of the porcine enzyme. For the forward primer a sequence in
the second exon and for the reverse primer a sequence in the third
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exon were selected and thus, the PCR fragment was expected to mi-
grate in the region of 500 bp. Out of the eight plaques shown to be
PH-GPx positive only one clone gave a PCR product of the expected
size. This PCR fragment was cloned into the pGEM-T cloning vector
and was sequenced completely. Since the sequence data suggested that
the construct contains PH-GPx genomic DNA this plaque was re-
plated at lower density. By DNA hybridization it was shown that
50% of the resulting plaques were PH-GPx positive (secondary
screen). One of these positive recombinants was picked, replated again
and 10 well isolated plaques were checked for the PH-GPx gene by
PCR (tertiary screen). Since all of the 10 clones gave the correct PCR
product one clone was picked, the DNA was isolated and sequenced.
Sequence alignments were carried out with the DNA Star software
package and the search for potential transcription factor binding sites
was performed with the Matinspector program [28].
3. Results
Three rounds of plaque hybridization of a mouse ¢broblast
cDNA library with a probe derived from the human PH-GPx
cDNA led to the isolation of a recombinant which contained
the mouse PH-GPx cDNA. Sequencing of the ¢nal construct
(in pBluescript II SK) indicated a cDNA size of 770 bp with
a 21 bp 5P-untranslated region and a 236 bp 3P-untranslated
region ending with a poly A signal. Nucleotides 157^159 of
our cDNA were identi¢ed as the TGA opal codon which is
suppressed in translation by the selenocysteine insertion se-
quence (SECIS) in the 3P-untranslated region of the cDNA
[23,29,30]. Since the sequence of ¢broblast PH-GPx cDNA
was identical to the PH-GPx cDNA recently isolated from
mouse testis [25], it will not be described here in more detail.
It should, however, be mentioned that the 5P-untranslated
region of our cDNA was some 200 bp shorter than the testis
cDNA but the missing part was obtained by analyzing the
PH-GPx gene (see below). Doing this we found a second
ATG start codon (5P-ATG) which was in frame with the pre-
viously identi¢ed ATG (3P-ATG). A similar constellation of
two in frame starting ATGs has been reported for the PH-
GPx cDNAs isolated from testis of rats, mice and humans
[22^25]. It has been suggested before that this additional
ATG (5P-ATG) constitutes the start codon for a putative sig-
nal peptide which may direct the protein into the mitochon-
dria [31].
During the ¢rst round of hybridization of a mouse genomic
library using two di¡erent probes derived from the cloned
mouse PH-GPx cDNA we identi¢ed eight PH-GPx positive
recombinants. These plaques were rescreened by PCR with
di¡erent primer combinations. PCR products of the expected
molecular weight were detected only for one of these eight
clones (Fig. 1). Three other recombinants (clones A, D and
F) gave PCR signals which were of the same molecular weight
as the PCR products obtained with the PH-GPx cDNA as
template. Size comparison and sequence data suggested that
these particular recombinants contained pseudogene(s) which
lack at least the second intron. The existence of pseudogenes
has already been reported for the classical GPx [32]. Four
other plaques (clones B, C, E and G) were PCR negative.
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Fig. 1. PCR analysis of genomic PH-GPx positive recombinants.
Among 210 000 recombinants tested by hybridization 10 plaques
were shown to be PH-GPx positive. These clones were isolated, the
DNA was prepared and PCR was carried out using the following
primers constructed from the sequence of the PH-GPx cDNA which
was cloned in this study: ACA TCG ACG GGC ACA TGG TCT
GCC TGG AT (forward) and CCA ACG TGG GTG GGC ATC
GTC CCC ATT TAC (reverse). Since these primers are localized in
exon 2 and exon 3 a PCR fragment of about 500 bp was expected
provided the exon/intron organizations of the mouse and porcine
PH-GPx gene are comparable. In contrast, when intron 2 is lacking
(pseudogenes), a 300 bp fragment is expected. PCR conditions: an-
nealing temperature 67‡C, denaturation temperature 94‡C, synthesis
temperature 72‡C, 30 cycles. PCR products were analyzed in a 2%
agarose gel. The sizes of the MW markers are as follows: 2176 bp,
1766 bp, 1230 bp, 1033 bp, 653 bp, 517 bp, 453 bp, 396 bp, 298
bp, 224/220 bp, 154 bp.
Table 1
Exon/intron organization of mouse, porcine and human PH-GPx genes
Structural element Length (bp)
mouse gene porcine gene [26] human gene [27]
5P-Flanking region (sequenced so far) 1013 615 n.p.
Exon 1 228 237a 163
Intron 1 797 980 1059
Exon 2 95 95 95
Intron 2 91 77 85
Exon 3 145 145 145
Intron 3 123 124 147
Exon 4 152 152 152
Intron 4 804 86 433
Exon 5 25 25 25
Intron 5 92 153 133
Exon 6 60 60 60
Intron 6 86 69 80
Exon 7 269b 252b 239b
aIncomplete cDNA, cap site concluded from sequence homology (Fig. 3).
bTo the poly A signal of the cDNA.
n.p., not published.
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Clone H was replated at lower density and rescreening by
hybridization indicated that about 50% of the resulting
plaques were PH-GPx positive (secondary screen). One of
the positive clones was picked and replated again. Ten of
the resulting plaques which were well separated from each
other were picked and all of them were PH-GPx positive by
PCR (tertiary screen). One of these clones was selected, the
DNA was isolated and sequencing indicated that it contained
a full length mouse PH-GPx gene. This gene spans a total
length of 3980 bp and is divided into seven exons and six
introns (Fig. 2). The exon/intron organization is very similar
to the porcine and human PH-GPx genes [26,27] with the
exception that intron 4 of the mouse gene is much larger
(Table 1). As mentioned above, we found a second ATG
starting codon (5P-ATG) in exon 1 which is in frame with
the ATG starting the translation of the cytosolic PH-GPx
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Fig. 3. Structural analysis of the 5P-£anking region of the PH-GPx genes. The 5P-£anking regions of the mouse (this paper) and porcine PH-
GPx genes [26] were aligned for maximal homology using the DNA Star software package (Macintosh version). Putative binding sites for tran-
scription factors (underlined) were analyzed with the Matinspector program [28]. Abbreviations: NFY (Y-box binding factor), IK2 (ikaros 2),
SP 1 (stimulating protein 1), GATA1 (GATA 1 binding protein), MZF1 (myeloic zinc ¢nger protein 1), NF1 (nuclear factor 1), AP1 (activating
protein 1), CMYB (protooncogene product CMYB), RORA1 (orphan hormone nuclear receptor), HFH1 (fork head domain factor), R (Ep-
stein-Barr virus transcription factor) or NRF2 (nuclear respiratory factor 2), NF-kappaB (transcription factor NF-UB), CREB (cAMP response
element), ATF1 (activating transcription factor 1). It should be stressed that the size of the full length cDNA (cap site) has only been deter-
mined experimentally in mice. However, the fact that the ¢rst 12 nucleotides in front of the mouse cap site are identical in the porcine gene
suggests that the porcine promoter also starts here (putative cap site).
Fig. 2. Structure of the mouse PH-GPx gene. The numbers above the boxes indicate the beginning of the structural elements (exons, introns,
£anking region). TGA* identi¢es the position of the opal TGA which encodes the catalytically active selenocysteine. The positions of the two
starting ATGs (exon 1), the stop codon and the SECIS (exon 7) are also indicated. The cap site was labeled nucleotide 1.
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(3P-ATG). Exon 3 contains the opal codon which encodes the
selenocysteine. The stop codon as well as the SECIS was
mapped to exon 7 (Fig. 2). The transcription initiation site
of the mouse PH-GPx gene was determined by comparing its
sequence with the structure of the full length cDNA [25]
obtained using the RACE technique (rapid ampli¢cation of
cDNA ends). In addition, we sequenced 1013 nucleotides of
the 5P-£anking region which may contain the promoter. The
sequence between positions 3422 and 31 was aligned to the
corresponding region of the porcine PH-GPx gene [26] and we
found a moderate degree of conservation (47% homology)
among the ¢rst 200 nucleotides proximal to the cap site
(Fig. 3). In contrast, the more distal parts of both genes
showed a lower degree of conservation (24% homology).
Neither the mouse nor porcine 5P-£anking regions contains
a TATA box at the canonical site of about 330. The binding
sites for NFY (Y-box binding factor), IK2 (ikaros 2), SP1
(stimulating protein 1) and MZF1 (myeloic zinc ¢nger protein
1) found in the mouse promoter have counterparts in the
porcine gene. A cluster of three GATA 1 elements (GATA
1 binding protein) was found in the mouse 5P-£anking region
(one GATA 1 element is present in the porcine promoter)
suggesting a role of PH-GPx expression in red cell biology.
Potential binding sites in the distal part of the porcine and
mouse 5P-£anking region do not share a high degree of sim-
ilarity, and thus it remains to be investigated whether the sites
indicated in Fig. 3 may be of functional relevance. Intron 1 of
the mouse gene contains binding sites for NF-UB and SP 1
which are also present in the porcine gene. Moreover, two
cAMP response elements (CREB) were found in exons 1 and
3 but they are not conserved in the porcine gene.
4. Discussion
Selenoproteins which contain selenium either as cofactor or
as selenocysteine amino acid are widespread in all life king-
doms [33]. Among the 11 genes encoding di¡erent selenocys-
teine containing proteins identi¢ed thus far in mammals four
encode various glutathione peroxidases [34] and three encode
di¡erent thyroid hormone deiodinases [29,35]. Others encode
thioredoxin reductase [36], selenophosphate synthase 2 [37]
and selenoproteins P and W [38,39]. Recently, a new selenium
containing protein has been identi¢ed in humans which does
not have a high degree of homology to other mammalian
selenoproteins. The biological relevance of this new protein
is currently unknown [33].
Glutathione peroxidases constitute an enzyme family which
can be divided into four di¡erent subtypes: the classical intra-
cellular glutathione peroxidase (GPx), the plasma glutathione
peroxidase (pGPx), the gastrointestinal glutathione peroxidase
(GI-GPx) and the phospholipid hydroperoxide glutathione
peroxidase (PH-GPx). These enzymes have attracted the at-
tention of scientists because of their potential antioxidative
capability. PH-GPx, which was discovered as second gluta-
thione peroxidase subtype in 1982 [40], is unique among these
peroxidases because it is capable of reducing hydroperoxy
ester lipids. Although the existence of a PH-GPx has been
known for more than 15 years [40,41], the molecular biology
of this enzyme subfamily has not been studied until recently.
In 1994 the ¢rst gene for a mammalian PH-GPx was se-
quenced [26] and in the same year the cDNA for the human
testis PH-GPx was cloned [24]. Later on PH-GPx cDNAs
from other mammalian tissues were isolated [22,23]. After
we had started this project three sequences for the mouse
PH-GPx cDNAs were released by the EMBL data bank
(AF045769, AF045768, D87896). These sequences were iden-
tical to each other and match exactly the mouse ¢broblast
PH-GPx cDNA sequenced in this study. The mouse PH-
GPx gene cloned in this study constitutes the second complete
mammalian PH-GPx gene sequenced so far and alignments of
the 5P-£anking region with that of the porcine gene suggested
structural elements which might be of regulatory importance.
The biological importance of the PH-GPx subfamily has
not been clari¢ed yet, but for the time being there are three
major hypotheses [42] : (i) protection against oxidative stress
[7^10], (ii) involvement in spermatogenesis [14^16], (iii) regu-
lator of the arachidonic acid cascade [17^20]. In addition,
there is circumstantial evidence for the implication of PH-
GPx in post-translational protein modi¢cation [41]. Most of
the experimental evidence suggesting the biological role of
glutathione peroxidases originates from animal studies carried
out under selenium de¢ciency. However, since glutathione
peroxidases are not the only selenoproteins in mammals the
results of such studies must be interpreted with care. More-
over, PH-GPx activity persists even under extreme selenium
de¢ciency [42,43], and thus selenium de¢ciency experiments
may not provide conclusive experimental data on the role of
PH-GPx. As a more convincing approach to obtain more
detailed information on the physiological relevance of the
PH-GPx, targeted gene disruption may be considered. Since
the stem cell technology for targeted gene disruption has
mainly been worked out in mice, cloning of the mouse PH-
GPx gene provided important tools for future knockout ex-
periments.
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